Concepedia

P. M. Hoff

PM

Statistics

Publications

3

Citations

80

H-Index

3

Active since

2005

Affiliations

Hospital Sírio-Libanês(Current)

P. M. Hoff is an author at Hospital Sírio-Libanês specializing in oncology, medicine, and oncology pharmacotherapy.

Publications per year

2005–2011

3

Publications

3

Improved progression free survival (PFS), and rapid, sustained decrease in tumor perfusion among patients with advanced carcinoid treated with bevacizumab

J. C. Yao, Chaan S. Ng, P. M. Hoff et al. · Journal of Clinical Oncology · 2005 · 57 citations

Medicine, Oncology, Pharmacology +17

A multinational, randomized phase III study of bevacizumab (Bev) with FOLFOX4 or XELOX versus FOLFOX4 alone as adjuvant treatment for colon cancer (CC): Subgroup analyses from the AVANT trial.

Thierry André, Eric Van Cutsem, Hans‐Joachim Schmoll et al. · Journal of Clinical Oncology · 2011 · 13 citations

Medicine, Oncology, Chemotherapy +16

Phase II study of infusional 5-fluorouracil, leucovorin, and irinotecan (FOLFIRI) plus bevacizumab as first-line treatment for metastatic colorectal cancer

Scott Kopetz, K. Y. Glover, Cathy Eng et al. · Journal of Clinical Oncology · 2007 · 10 citations

Medicine, Oncology, Pharmacology +6

1–3 of 3